Cargando…

Tumor Volume Dynamics as an Early Biomarker for Patient-Specific Evolution of Resistance and Progression in Recurrent High-Grade Glioma

Recurrent high-grade glioma (HGG) remains incurable with inevitable evolution of resistance and high inter-patient heterogeneity in time to progression (TTP). Here, we evaluate if early tumor volume response dynamics can calibrate a mathematical model to predict patient-specific resistance to develo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glazar, Daniel J., Grass, G. Daniel, Arrington, John A., Forsyth, Peter A., Raghunand, Natarajan, Yu, Hsiang-Hsuan Michael, Sahebjam, Solmaz, Enderling, Heiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409184/ https://www.ncbi.nlm.nih.gov/pubmed/32605050 http://dx.doi.org/10.3390/jcm9072019

Ejemplares similares

Rules-based Volumetric Segmentation of Multiparametric MRI for Response Assessment in Recurrent High-Grade Glioma
por: Ravi, Harshan, et al.
Publicado: (2023)

Intermittent radiotherapy as alternative treatment for recurrent high grade glioma: a modeling study based on longitudinal tumor measurements
por: Brüningk, Sarah C., et al.
Publicado: (2021)

Author Correction: Intermittent radiotherapy as alternative treatment for recurrent high grade glioma: a modeling study based on longitudinal tumor measurements
por: Brüningk, Sarah C., et al.
Publicado: (2022)

Revisiting the Concept of Recurrence of Primary Central Nervous System Lymphomas After Complete Response to Methotrexate-Based Therapy: Periventricular Reseeding as the Predominant Mechanism of Recurrence
por: Kutuk, Tugce, et al.
Publicado: (2022)

Durable Progression-Free Survival With the Use of BRAF and MEK Inhibitors in Four Cases With BRAF V600E-Mutated Gliomas
por: Fusco, Michael J., et al.
Publicado: (2021)

Efficacy of Gamma Knife Radiosurgery for Recurrent High-Grade Gliomas with Limited Tumor Volume
por: Cheon, Young-Jun, et al.
Publicado: (2018)

Evolution and Phenotypic Selection of Cancer Stem Cells
por: Poleszczuk, Jan, et al.
Publicado: (2015)

Re: Simulation analysis for tumor radiotherapy based on three‐component mathematical models
por: Ferrall‐Fairbanks, Meghan C., et al.
Publicado: (2019)

Temozolomide and Reirradiation in Recurrent Grade II Brain Glioma
por: Osman, Mohammed A
Publicado: (2014)

Tumor morphological evolution: directed migration and gain and loss of the self-metastatic phenotype
por: Enderling, Heiko, et al.
Publicado: (2010)

Radiosurgery and Stereotactic Brain Radiotherapy with Systemic Therapy in Recurrent High-Grade Gliomas: Is It Feasible? Therapeutic Strategies in Recurrent High-Grade Gliomas
por: Gregucci, Fabiana, et al.
Publicado: (2022)

Re-irradiation alternatives for recurrent high-grade glioma
por: Dong, Yuanli, et al.
Publicado: (2016)

Bevacizumab in recurrent WHO grades II–III glioma
por: Annakib, Soufyan, et al.
Publicado: (2023)

Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy
por: Teng, Chubei, et al.
Publicado: (2022)

Emerging Biomarkers in Glioblastoma
por: McNamara, Mairéad G., et al.
Publicado: (2013)

Carbon Ion Beam Reirradiation in Recurrent High-Grade Glioma
por: Eberle, Fabian, et al.
Publicado: (2020)

Decisional needs of patients with recurrent high-grade glioma and their families
por: Sorensen von Essen, Helle, et al.
Publicado: (2022)

Modeling YAP fusions: a paradigm for investigating rare cancers?
por: Sahebjam, Solmaz, et al.
Publicado: (2022)

A stochastic hierarchical model for low grade glioma evolution
por: Buckwar, Evelyn, et al.
Publicado: (2023)

Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma
por: Franceschi, E, et al.
Publicado: (2004)

Recurrent TRAK1::RAF1 Fusions in pediatric low‐grade gliomas
por: Benhamida, Jamal K., et al.
Publicado: (2023)

Unveiling Stem Cell Kinetics: Prime Time for Integrating Experimental and Computational Models
por: Enderling, Heiko
Publicado: (2013)

Management of supratentorial recurrent low-grade glioma: A multidisciplinary experience in 35 adult patients
por: Spitaels, Julien, et al.
Publicado: (2017)

NFB-13. TRAMETINIB FOR PLEXIFORM NEUROFIBROMA AND RECURRENT LOW-GRADE GLIOMA
por: Sato, Aimee, et al.
Publicado: (2020)

The role of large volume re-irradiation with Bevacizumab in chemorefractory high grade glioma
por: Chan, Joseph, et al.
Publicado: (2020)

Impact of (18)F-FET PET on Target Volume Definition and Tumor Progression of Recurrent High Grade Glioma Treated with Carbon-Ion Radiotherapy
por: Debus, Charlotte, et al.
Publicado: (2018)

Stereotactic Radiosurgery for the Treatment of Recurrent High-grade Gliomas: Long-term Follow-up
por: Sallabanda, Kita, et al.
Publicado: (2019)

Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review
por: Kulinich, Daniel P., et al.
Publicado: (2021)

Bridging cell-scale simulations and radiologic images to explain short-time intratumoral oxygen fluctuations
por: Kingsley, Jessica L., et al.
Publicado: (2021)

EASE: Clinical Implementation of Automated Tumor Segmentation and Volume Quantification for Adult Low-Grade Glioma
por: van Garderen, Karin A., et al.
Publicado: (2021)

Relevance of two manual tumour volume estimation methods for diffuse low-grade gliomas
por: Ben Abdallah, Meriem, et al.
Publicado: (2018)

Impact of Postoperative Changes in Brain Anatomy on Target Volume Delineation for High-Grade Glioma
por: Dejonckheere, Cas Stefaan, et al.
Publicado: (2023)

Leptomeningeal Dissemination of a Low-Grade Brainstem Glioma without Local Recurrence
por: Moon, Jung-Ho, et al.
Publicado: (2012)

A Review of the Role of Re-Irradiation in Recurrent High-Grade Glioma (HGG)
por: Amichetti, Maurizio, et al.
Publicado: (2011)

Platinum-based Chemotherapy in Recurrent High-grade Glioma Patients: Retrospective Study
por: Roci, Ermir, et al.
Publicado: (2014)

Recurrence patterns in patients with high-grade glioma following temozolomide-based chemoradiotherapy
por: Zhou, Xiaofeng, et al.
Publicado: (2016)

Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020)

(11)C-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence
por: Bag, Asim K., et al.
Publicado: (2022)

Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas
por: Zhang, Ming, et al.
Publicado: (2022)

Pseudoprogression in low-grade glioma
por: Slater, Jason M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t5d577b21turd68b5nbta8fd6u